Manila Times Business
Oculis to Present Privosegtor at Upcoming Clinical Trials at the Summit 2026
ZUG, Switzerland, June 11, 2026 - Oculis Holding AG (Nasdaq: OCS; XICE: OCS) ("Oculis” or the "Company”), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology and ophthalmology, today announced an upcoming presentation at Clinical Trials at the Summit 2026, taking place on June 12-13, 2026, in Las Vegas, Nevada. Oculis is a proud sponsor of Clinical Trials at the Summit 2026, which brings together experts from ar
This is an excerpt. Read the full article at the original source:
Source: manilatimes.net
Read Full Article on manilatimes.net →More from Manila Times Business
Ambros Therapeutics Appoints Cris Calsada as Chief Financial Officer and Claire Padgett, Ph.D., as SVP of Clinical Operations and Program Management
Just now
Manganese X Energy to Present at the June 16 Energy & Precious Metals Virtual Investor Summit
Just now
Energy & Precious Metals Virtual Investor Summit Agenda Announced for June 16th
Just now
WatchMatic Highlights Market Trends Influencing Luxury Watch Investment Strategies
Just now